RetinalGenix Technologies Inc. financial data

Symbol
RTGN on OTC
Location
1450 North Mcdowell Boulevard, Suite 150, Petaluma, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.15 %
Debt-to-equity -101 % +2.77%
Return On Equity 147 % -39.5%
Return On Assets -25.3K % -259%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.6M shares +2.84%
Common Stock, Shares, Outstanding 18.6M shares +3.02%
Entity Public Float 15.5M USD 0%
Common Stock, Value, Issued 1.86K USD +2.99%
Weighted Average Number of Shares Outstanding, Basic 18.6M shares +3.39%
Weighted Average Number of Shares Outstanding, Diluted 18.6M shares +3.39%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 152K USD -80.1%
General and Administrative Expense 1.39M USD +2.75%
Net Income (Loss) Attributable to Parent -2.67M USD +33.1%
Earnings Per Share, Basic 0 USD/shares +43.5%
Earnings Per Share, Diluted 0 USD/shares +43.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 44 USD -98.8%
Assets, Current 92 USD -99.9%
Property, Plant and Equipment, Net 31 USD -76.3%
Operating Lease, Right-of-Use Asset 4.91K USD -36.1%
Assets 7K USD -92.1%
Liabilities, Current 2.17M USD +12.3%
Operating Lease, Liability, Noncurrent 6K USD -14.6%
Liabilities 2.18M USD +12.2%
Retained Earnings (Accumulated Deficit) -17.2M USD -18.4%
Stockholders' Equity Attributable to Parent -2.17M USD -17.2%
Liabilities and Equity 7K USD -92.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -187K USD -14.3%
Net Cash Provided by (Used in) Financing Activities 185K USD -13.7%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 18.6M shares +3.02%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.35K USD -105%
Deferred Tax Assets, Valuation Allowance 4.61M USD +39.1%
Deferred Tax Assets, Gross 4.61M USD +39.1%
Operating Lease, Liability 6K USD -22%
Depreciation 25 USD 0%
Lessee, Operating Lease, Liability, to be Paid 15.7K USD -35%
Operating Lease, Liability, Current 988 USD +49.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.52K USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.11K USD +3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.66K USD -41.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.52K USD
Deferred Tax Assets, Operating Loss Carryforwards 1.77M USD +23.3%
Preferred Stock, Shares Authorized 40M shares 0%
Operating Lease, Payments 7.69K USD
Additional Paid in Capital 15.1M USD +18.5%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 3.84K USD -17.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%